Atlas Trials

Efficacy of Erlotinib for Brain Metastasis of Non-Small Cell Lung Cancer

Clinical trial NCT00663689 · UNKNOWN

Trial details

NCT number
NCT00663689
Sponsor
Guangdong Provincial People's Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Non-Small Cell Lung CancerBrain Metastases
Start date
2008-03-01
Primary completion
2011-03-01
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.